Cairo – Mubasher: Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) reported a 111% year-on-year (YoY) increase in its net profits to EGP 43.47 million during the first half (H1) of 2020, compared to EGP 20.6 million.

In the meantime, Rameda’s revenues grew to EGP 437.46 million in the January-June period from EGP 384.3 million in the year-ago period, according to a bourse disclosure on Sunday.

During the first quarter (Q1) of 2020, the company’s net profits surged to EGP 23.76 million from EGP 8.33 million in the same period in 2019.